We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
PDE4D
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • PDE4D
PROTEIN STRUCTURE
ANTIBODIES
AND
VALIDATION
Protein structures
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

PDE4D
Synonyms DPDE3
Gene descriptioni

Full gene name according to HGNC.

Phosphodiesterase 4D
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Read more
Disease related genes
Enzymes
FDA approved drug targets
Human disease related genes
Metabolic proteins
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 5
Cytoband
Chromosome location (bp) 58969038 - 60522120
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

16
Ensembl ENSG00000113448 (version 103.38)
Entrez gene 5144
HGNC HGNC:8783
UniProt Q08499 (UniProt - Evidence at protein level)
neXtProt NX_Q08499
Antibodypedia PDE4D antibodies


PROTEIN STRUCTUREi

The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).

In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl

Read more

Predicted


Description: Structure prediction from Alphafold project. Structure version 2

# Chains: 1      # Clinical variants: 12      # Population variants: 290

Experimental

Description: Crystal structure of PDE4D2 in complex with inhibitor (S_Zl-n-91) (X-ray)

# Chains: 1      # Clinical variants: 6      # Population variants: 147

Antigens:

Off
On

Variants:

Off
Clinical
Population

Color scheme:

Confidence
Residue index
Chain name

Autorotate:

Off
On



PROTEIN BROWSERi

The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.

At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.

Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).

The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).

If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.

Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
«
PDE4D-202
PDE4D-203
PDE4D-204
PDE4D-205
PDE4D-207
PDE4D-208
PDE4D-209
PDE4D-210
PDE4D-212
PDE4D-213
PDE4D-216
PDE4D-222
PDE4D-225
PDE4D-226
PDE4D-228
PDE4D-229
»


PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Splice variant UniProt Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
PDE4D-202
ENSP00000321739
ENST00000317118
Q08499 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002027 [regulation of heart rate]
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005886 [plasma membrane]
GO:0005891 [voltage-gated calcium channel complex]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0007186 [G protein-coupled receptor signaling pathway]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0010469 [regulation of signaling receptor activity]
GO:0010880 [regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum]
GO:0016020 [membrane]
GO:0016324 [apical plasma membrane]
GO:0016787 [hydrolase activity]
GO:0019899 [enzyme binding]
GO:0019933 [cAMP-mediated signaling]
GO:0030552 [cAMP binding]
GO:0031698 [beta-2 adrenergic receptor binding]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0032743 [positive regulation of interleukin-2 production]
GO:0032754 [positive regulation of interleukin-5 production]
GO:0033137 [negative regulation of peptidyl-serine phosphorylation]
GO:0034704 [calcium channel complex]
GO:0043951 [negative regulation of cAMP-mediated signaling]
GO:0044325 [ion channel binding]
GO:0045822 [negative regulation of heart contraction]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050852 [T cell receptor signaling pathway]
GO:0051117 [ATPase binding]
GO:0060314 [regulation of ryanodine-sensitive calcium-release channel activity]
GO:0061028 [establishment of endothelial barrier]
GO:0071875 [adrenergic receptor signaling pathway]
GO:0086004 [regulation of cardiac muscle cell contraction]
GO:0086024 [adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate]
GO:0097110 [scaffold protein binding]
GO:1901363 [heterocyclic compound binding]
GO:1901844 [regulation of cell communication by electrical coupling involved in cardiac conduction]
GO:1901898 [negative regulation of relaxation of cardiac muscle]
Show all
518 aa
59.1 kDa
No 0
PDE4D-203
ENSP00000345502
ENST00000340635
Q08499 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
A0A140VJR0 [Target identity:100%; Query identity:100%]
Phosphodiesterase
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002027 [regulation of heart rate]
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005886 [plasma membrane]
GO:0005891 [voltage-gated calcium channel complex]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0007186 [G protein-coupled receptor signaling pathway]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0010469 [regulation of signaling receptor activity]
GO:0010880 [regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum]
GO:0016020 [membrane]
GO:0016324 [apical plasma membrane]
GO:0016787 [hydrolase activity]
GO:0019899 [enzyme binding]
GO:0019933 [cAMP-mediated signaling]
GO:0030552 [cAMP binding]
GO:0031698 [beta-2 adrenergic receptor binding]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0032743 [positive regulation of interleukin-2 production]
GO:0032754 [positive regulation of interleukin-5 production]
GO:0033137 [negative regulation of peptidyl-serine phosphorylation]
GO:0034704 [calcium channel complex]
GO:0043951 [negative regulation of cAMP-mediated signaling]
GO:0044325 [ion channel binding]
GO:0045822 [negative regulation of heart contraction]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050852 [T cell receptor signaling pathway]
GO:0051117 [ATPase binding]
GO:0060314 [regulation of ryanodine-sensitive calcium-release channel activity]
GO:0061028 [establishment of endothelial barrier]
GO:0071875 [adrenergic receptor signaling pathway]
GO:0086004 [regulation of cardiac muscle cell contraction]
GO:0086024 [adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate]
GO:0097110 [scaffold protein binding]
GO:1901363 [heterocyclic compound binding]
GO:1901844 [regulation of cell communication by electrical coupling involved in cardiac conduction]
GO:1901898 [negative regulation of relaxation of cardiac muscle]
Show all
809 aa
91.1 kDa
No 0
PDE4D-204
ENSP00000351800
ENST00000358923
Q08499 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002027 [regulation of heart rate]
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005886 [plasma membrane]
GO:0005891 [voltage-gated calcium channel complex]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0007186 [G protein-coupled receptor signaling pathway]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0010469 [regulation of signaling receptor activity]
GO:0010880 [regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum]
GO:0016020 [membrane]
GO:0016324 [apical plasma membrane]
GO:0016787 [hydrolase activity]
GO:0019899 [enzyme binding]
GO:0019933 [cAMP-mediated signaling]
GO:0030552 [cAMP binding]
GO:0031698 [beta-2 adrenergic receptor binding]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0032743 [positive regulation of interleukin-2 production]
GO:0032754 [positive regulation of interleukin-5 production]
GO:0033137 [negative regulation of peptidyl-serine phosphorylation]
GO:0034704 [calcium channel complex]
GO:0043951 [negative regulation of cAMP-mediated signaling]
GO:0044325 [ion channel binding]
GO:0045822 [negative regulation of heart contraction]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050852 [T cell receptor signaling pathway]
GO:0051117 [ATPase binding]
GO:0060314 [regulation of ryanodine-sensitive calcium-release channel activity]
GO:0061028 [establishment of endothelial barrier]
GO:0071875 [adrenergic receptor signaling pathway]
GO:0086004 [regulation of cardiac muscle cell contraction]
GO:0086024 [adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate]
GO:0097110 [scaffold protein binding]
GO:1901363 [heterocyclic compound binding]
GO:1901844 [regulation of cell communication by electrical coupling involved in cardiac conduction]
GO:1901898 [negative regulation of relaxation of cardiac muscle]
Show all
507 aa
57.8 kDa
No 0
PDE4D-205
ENSP00000353152
ENST00000360047
Q08499 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002027 [regulation of heart rate]
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005886 [plasma membrane]
GO:0005891 [voltage-gated calcium channel complex]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0007186 [G protein-coupled receptor signaling pathway]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0010469 [regulation of signaling receptor activity]
GO:0010880 [regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum]
GO:0016020 [membrane]
GO:0016324 [apical plasma membrane]
GO:0016787 [hydrolase activity]
GO:0019899 [enzyme binding]
GO:0019933 [cAMP-mediated signaling]
GO:0030552 [cAMP binding]
GO:0031698 [beta-2 adrenergic receptor binding]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0032743 [positive regulation of interleukin-2 production]
GO:0032754 [positive regulation of interleukin-5 production]
GO:0033137 [negative regulation of peptidyl-serine phosphorylation]
GO:0034704 [calcium channel complex]
GO:0043951 [negative regulation of cAMP-mediated signaling]
GO:0044325 [ion channel binding]
GO:0045822 [negative regulation of heart contraction]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050852 [T cell receptor signaling pathway]
GO:0051117 [ATPase binding]
GO:0060314 [regulation of ryanodine-sensitive calcium-release channel activity]
GO:0061028 [establishment of endothelial barrier]
GO:0071875 [adrenergic receptor signaling pathway]
GO:0086004 [regulation of cardiac muscle cell contraction]
GO:0086024 [adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate]
GO:0097110 [scaffold protein binding]
GO:1901363 [heterocyclic compound binding]
GO:1901844 [regulation of cell communication by electrical coupling involved in cardiac conduction]
GO:1901898 [negative regulation of relaxation of cardiac muscle]
Show all
673 aa
76.5 kDa
No 0
PDE4D-207
ENSP00000384806
ENST00000405755
Q08499 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002027 [regulation of heart rate]
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005886 [plasma membrane]
GO:0005891 [voltage-gated calcium channel complex]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0007186 [G protein-coupled receptor signaling pathway]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0010469 [regulation of signaling receptor activity]
GO:0010880 [regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum]
GO:0016020 [membrane]
GO:0016324 [apical plasma membrane]
GO:0016787 [hydrolase activity]
GO:0019899 [enzyme binding]
GO:0019933 [cAMP-mediated signaling]
GO:0030552 [cAMP binding]
GO:0031698 [beta-2 adrenergic receptor binding]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0032743 [positive regulation of interleukin-2 production]
GO:0032754 [positive regulation of interleukin-5 production]
GO:0033137 [negative regulation of peptidyl-serine phosphorylation]
GO:0034704 [calcium channel complex]
GO:0043951 [negative regulation of cAMP-mediated signaling]
GO:0044325 [ion channel binding]
GO:0045822 [negative regulation of heart contraction]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050852 [T cell receptor signaling pathway]
GO:0051117 [ATPase binding]
GO:0060314 [regulation of ryanodine-sensitive calcium-release channel activity]
GO:0061028 [establishment of endothelial barrier]
GO:0071875 [adrenergic receptor signaling pathway]
GO:0086004 [regulation of cardiac muscle cell contraction]
GO:0086024 [adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate]
GO:0097110 [scaffold protein binding]
GO:1901363 [heterocyclic compound binding]
GO:1901844 [regulation of cell communication by electrical coupling involved in cardiac conduction]
GO:1901898 [negative regulation of relaxation of cardiac muscle]
Show all
687 aa
77.7 kDa
No 0
PDE4D-208
ENSP00000423094
ENST00000502484
Q08499 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002027 [regulation of heart rate]
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005886 [plasma membrane]
GO:0005891 [voltage-gated calcium channel complex]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0007186 [G protein-coupled receptor signaling pathway]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0010469 [regulation of signaling receptor activity]
GO:0010880 [regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum]
GO:0016020 [membrane]
GO:0016324 [apical plasma membrane]
GO:0016787 [hydrolase activity]
GO:0019899 [enzyme binding]
GO:0019933 [cAMP-mediated signaling]
GO:0030552 [cAMP binding]
GO:0031698 [beta-2 adrenergic receptor binding]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0032743 [positive regulation of interleukin-2 production]
GO:0032754 [positive regulation of interleukin-5 production]
GO:0033137 [negative regulation of peptidyl-serine phosphorylation]
GO:0034704 [calcium channel complex]
GO:0043951 [negative regulation of cAMP-mediated signaling]
GO:0044325 [ion channel binding]
GO:0045822 [negative regulation of heart contraction]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050852 [T cell receptor signaling pathway]
GO:0051117 [ATPase binding]
GO:0060314 [regulation of ryanodine-sensitive calcium-release channel activity]
GO:0061028 [establishment of endothelial barrier]
GO:0071875 [adrenergic receptor signaling pathway]
GO:0086004 [regulation of cardiac muscle cell contraction]
GO:0086024 [adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate]
GO:0097110 [scaffold protein binding]
GO:1901363 [heterocyclic compound binding]
GO:1901844 [regulation of cell communication by electrical coupling involved in cardiac conduction]
GO:1901898 [negative regulation of relaxation of cardiac muscle]
Show all
748 aa
84.7 kDa
No 0
PDE4D-209
ENSP00000425917
ENST00000502575
Q08499 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002027 [regulation of heart rate]
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005886 [plasma membrane]
GO:0005891 [voltage-gated calcium channel complex]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0007186 [G protein-coupled receptor signaling pathway]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0010469 [regulation of signaling receptor activity]
GO:0010880 [regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum]
GO:0016020 [membrane]
GO:0016324 [apical plasma membrane]
GO:0016787 [hydrolase activity]
GO:0019899 [enzyme binding]
GO:0019933 [cAMP-mediated signaling]
GO:0030552 [cAMP binding]
GO:0031698 [beta-2 adrenergic receptor binding]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0032743 [positive regulation of interleukin-2 production]
GO:0032754 [positive regulation of interleukin-5 production]
GO:0033137 [negative regulation of peptidyl-serine phosphorylation]
GO:0034704 [calcium channel complex]
GO:0043951 [negative regulation of cAMP-mediated signaling]
GO:0044325 [ion channel binding]
GO:0045822 [negative regulation of heart contraction]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050852 [T cell receptor signaling pathway]
GO:0051117 [ATPase binding]
GO:0060314 [regulation of ryanodine-sensitive calcium-release channel activity]
GO:0061028 [establishment of endothelial barrier]
GO:0071875 [adrenergic receptor signaling pathway]
GO:0086004 [regulation of cardiac muscle cell contraction]
GO:0086024 [adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate]
GO:0097110 [scaffold protein binding]
GO:1901363 [heterocyclic compound binding]
GO:1901844 [regulation of cell communication by electrical coupling involved in cardiac conduction]
GO:1901898 [negative regulation of relaxation of cardiac muscle]
Show all
219 aa
24.4 kDa
No 0
PDE4D-210
ENSP00000425605
ENST00000503258
Q08499 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002027 [regulation of heart rate]
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005886 [plasma membrane]
GO:0005891 [voltage-gated calcium channel complex]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0007186 [G protein-coupled receptor signaling pathway]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0010469 [regulation of signaling receptor activity]
GO:0010880 [regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum]
GO:0016020 [membrane]
GO:0016324 [apical plasma membrane]
GO:0016787 [hydrolase activity]
GO:0019899 [enzyme binding]
GO:0019933 [cAMP-mediated signaling]
GO:0030552 [cAMP binding]
GO:0031698 [beta-2 adrenergic receptor binding]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0032743 [positive regulation of interleukin-2 production]
GO:0032754 [positive regulation of interleukin-5 production]
GO:0033137 [negative regulation of peptidyl-serine phosphorylation]
GO:0034704 [calcium channel complex]
GO:0043951 [negative regulation of cAMP-mediated signaling]
GO:0044325 [ion channel binding]
GO:0045822 [negative regulation of heart contraction]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050852 [T cell receptor signaling pathway]
GO:0051117 [ATPase binding]
GO:0060314 [regulation of ryanodine-sensitive calcium-release channel activity]
GO:0061028 [establishment of endothelial barrier]
GO:0071875 [adrenergic receptor signaling pathway]
GO:0086004 [regulation of cardiac muscle cell contraction]
GO:0086024 [adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate]
GO:0097110 [scaffold protein binding]
GO:1901363 [heterocyclic compound binding]
GO:1901844 [regulation of cell communication by electrical coupling involved in cardiac conduction]
GO:1901898 [negative regulation of relaxation of cardiac muscle]
Show all
679 aa
76.8 kDa
No 0
PDE4D-212
ENSP00000421013
ENST00000505453
D6RHE0 [Direct mapping]
Phosphodiesterase
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0016787 [hydrolase activity]
GO:0046872 [metal ion binding]
Show all
422 aa
48.4 kDa
No 0
PDE4D-213
ENSP00000425910
ENST00000505507
D6RIG1 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Protein evidence (Ezkurdia et al 2014)
Show all
81 aa
9.4 kDa
No 0
PDE4D-216
ENSP00000424852
ENST00000507116
Q08499 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002027 [regulation of heart rate]
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005815 [microtubule organizing center]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005886 [plasma membrane]
GO:0005891 [voltage-gated calcium channel complex]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0007186 [G protein-coupled receptor signaling pathway]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0010469 [regulation of signaling receptor activity]
GO:0010880 [regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum]
GO:0016020 [membrane]
GO:0016324 [apical plasma membrane]
GO:0016787 [hydrolase activity]
GO:0019899 [enzyme binding]
GO:0019933 [cAMP-mediated signaling]
GO:0030552 [cAMP binding]
GO:0031698 [beta-2 adrenergic receptor binding]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0032743 [positive regulation of interleukin-2 production]
GO:0032754 [positive regulation of interleukin-5 production]
GO:0033137 [negative regulation of peptidyl-serine phosphorylation]
GO:0034704 [calcium channel complex]
GO:0043951 [negative regulation of cAMP-mediated signaling]
GO:0044325 [ion channel binding]
GO:0045822 [negative regulation of heart contraction]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050852 [T cell receptor signaling pathway]
GO:0051117 [ATPase binding]
GO:0060314 [regulation of ryanodine-sensitive calcium-release channel activity]
GO:0061028 [establishment of endothelial barrier]
GO:0071320 [cellular response to cAMP]
GO:0071872 [cellular response to epinephrine stimulus]
GO:0071875 [adrenergic receptor signaling pathway]
GO:0086004 [regulation of cardiac muscle cell contraction]
GO:0086024 [adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate]
GO:0097110 [scaffold protein binding]
GO:1901363 [heterocyclic compound binding]
GO:1901844 [regulation of cell communication by electrical coupling involved in cardiac conduction]
GO:1901898 [negative regulation of relaxation of cardiac muscle]
Show all
745 aa
84.4 kDa
No 0
PDE4D-222
ENSP00000421829
ENST00000514552
D6RAQ0 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Protein evidence (Ezkurdia et al 2014)
Show all
74 aa
8.6 kDa
No 0
PDE4D-225
ENSP00000424281
ENST00000515835
D6RBB2 [Direct mapping]
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Protein evidence (Ezkurdia et al 2014)
Show all
29 aa
3.4 kDa
No 0
PDE4D-226
ENSP00000442734
ENST00000546160
A0A087WSZ7 [Direct mapping]
Phosphodiesterase
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0016787 [hydrolase activity]
GO:0046872 [metal ion binding]
Show all
678 aa
77 kDa
No 0
PDE4D-228
ENSP00000490821
ENST00000636120
A0A1B0GW84 [Direct mapping]
Phosphodiesterase
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004114 [3',5'-cyclic-nucleotide phosphodiesterase activity]
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006198 [cAMP catabolic process]
GO:0007165 [signal transduction]
GO:0008081 [phosphoric diester hydrolase activity]
GO:0016787 [hydrolase activity]
GO:0046872 [metal ion binding]
Show all
699 aa
79.2 kDa
No 0
PDE4D-229
ENSP00000492052
ENST00000638939
A0A1W2PQN6 [Direct mapping]
3',5'-cyclic-AMP phosphodiesterase
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Human disease related genes
   Congenital malformations
   Congenital malformations of the musculoskeletal system
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004115 [3',5'-cyclic-AMP phosphodiesterase activity]
GO:0006198 [cAMP catabolic process]
GO:0016787 [hydrolase activity]
Show all
125 aa
13.5 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.